Public company
Roivant Sciences Ltd.
ROIVCIK 0001635088
Price$38.88
1 year+92.2%
Disclosed transactions30
Buys / sells0 / 8
Max Insider Score35
Connections with evidence10
ROIV · disclosed activity on price
Disclosed transactions
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 11 | Venker EricPresident & Immunovant CEO | ROIVRoivant Sciences Ltd. Open-market sale · 10b5-1 plan | SELL | $7.26M 200.0K sh | Nov 5, 2026 |
Verified connections
- In industryevidencePharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
- ← Holds over 5% ofevidenceFMR LLC11.8% of class · Schedule 13G · Nov 4, 2026
- ← Insider ofevidenceSukhatme MayukhDirector, President & CIO · Oct 20, 2026
- ← Insider ofevidenceOren IlanDirector · Sep 18, 2026
- ← Insider ofevidence